Company Search:
Advanced Search
Sponsored Links
ArQule, Inc. Company Snapshot
ArQule, Inc. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ArQule with three other companies in this sector in the United States: Chimerix Inc (2015 sales of $10.76 million of which 100% was Pharmaceutical), Onconova Therapeutics Inc ($11.46 million of which 100% was Identification and), and Tetraphase Pharmaceuticals Inc ($11.69 million of which 100% was Biopharmaceuticals).

Sales Analysis. During the year ended December of 2015, sales at ArQule were $11.24 million. This is a decrease of 0.1% versus 2014, when the company's sales were $11.25 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ArQule, Inc.
  Stock Performance Chart for ArQule, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 1.58
(Figures in U.S. Dollars)
1 Week 18.8%   13 Weeks 21.5%  
4 Weeks 3.9%   52 Weeks -11.2%  
ArQule, Inc. Key Data:
  Ticker: ARQL Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 11,239,000
(Year Ending Jan 2016).
Employees: 36
  Currency: U.S. Dollars Market Cap: 112,367,560
  Fiscal Yr Ends: December Shares Outstanding: 71,118,709
  Share Type: Common Closely Held Shares: 4,275,055
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.